Vasculitis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Categories) |
||
Line 18: | Line 18: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Rheumatology]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 13:51, 15 June 2016
Vasculitis |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: M.Umer Tariq [2]
Overview
Medical Therapy
Treatment is targeted to the underlying cause. However, most vasculitis in general are treated with steroids (e.g. methylprednisolone) because the underlying cause of the vasculitis is due to hyperactive immunological damage. Immunosuppressants such as cyclophosphamide and azathioprine may also be given.
A systematic review of antineutrophil cytoplasmic antibody (ANCA) positive vasculitis indentified best treatments depending on whether the goal is to induce remission or maintenance and depending on severity of the vasculitis.[1]
Contraindicated medications
Vasculitis is considered an absolute contraindication to the use of the following medications:
References
- ↑ Bosch X, Guilabert A, Espinosa G, Mirapeix E (2007). "Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review". JAMA. 298 (6): 655–69. doi:10.1001/jama.298.6.655. PMID 17684188.